Nkarta (NKTX) Retained Earnings (2019 - 2026)
Nkarta (NKTX) posted quarterly Retained Earnings of -$676.1 million for Q1 2026, down 17.34% year-over-year from -$817.9 million in Q1 2025, and down 4.29% quarter-over-quarter from -$648.3 million in Q4 2025.
Nkarta (NKTX) Retained Earnings (2019 - 2026) Analysis & Trends
Nkarta's Retained Earnings history runs 8 years deep, the most recent figure standing at -$676.1 million for Q1 2026.
- In Q1 2026, Retained Earnings fell 17.34% year-over-year to -$676.1 million; the TTM figure through Mar 2026 stood at -$676.1 million (down 17.34% YoY), while the FY2025 annual figure was -$648.3 million, down 19.13% from the prior year.
- Retained Earnings for Q1 2026 stood at -$676.1 million, down from -$648.3 million in the prior quarter.
- The five-year high for Retained Earnings was $536000.0 in Q3 2025, with the low at -$676.1 million in Q1 2026.
- The 5-year median for Retained Earnings is -$285.4 million (2022), against an average of -$277.7 million.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings tumbled 6802900.0% in 2024, then soared 100.1% in 2025.
- Nkarta's Retained Earnings stood at -$317.9 million in 2022, then soared by 100.0% to $8000.0 in 2023, then sank by 6802900.0% to -$544.2 million in 2024, then slipped by 19.13% to -$648.3 million in 2025, then dropped by 4.29% to -$676.1 million in 2026.
- Business Quant data shows NKTX's Retained Earnings at -$676.1 million in Q1 2026, -$648.3 million in Q4 2025, and $536000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 4.38 Bn |
| 10 | Nkarta | 201.14 Mn | 201.14 Mn | - | -716.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -716.51 Mn |
| Mar 31, 2026 | -676.10 Mn |
| Dec 31, 2025 | -648.31 Mn |
| Sep 30, 2025 | 536,000.00 |
| Jun 30, 2025 | 362,000.00 |
| Mar 31, 2025 | -576.20 Mn |
| Dec 31, 2024 | -544.22 Mn |
| Sep 30, 2024 | -518.30 Mn |
| Jun 30, 2024 | -489.90 Mn |
| Mar 31, 2024 | -127,000.00 |
| Dec 31, 2023 | 8,000.00 |
| Sep 30, 2023 | -407.68 Mn |
| Jun 30, 2023 | -601,000.00 |
| Mar 31, 2023 | -174,000.00 |
| Dec 31, 2022 | -317.93 Mn |
| Sep 30, 2022 | -285.35 Mn |
| Jun 30, 2022 | -257.00 Mn |
| Mar 31, 2022 | -606,000.00 |
| Dec 31, 2021 | -204.10 Mn |
| Sep 30, 2021 | -30,000.00 |